Tech Company Financing Transactions
NaNotics Funding Round
NaNotics closed a financing round on 10/31/2023. Backers included LifeSpan Vision Ventures.
Transaction Overview
Company Name
Announced On
10/31/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
LifeSpan Vision Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to continue to expand its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Shoreline Highway B100
Mill Valley, CA 94941
USA
Mill Valley, CA 94941
USA
Phone
Undisclosed
Website
Email Address
Overview
NaNotics is a medical platform created to treat autoimmune disorders and solid tumor malignancies. The business's platform comprises extractors that eliminate particular circulating molecular signals or signal inhibitors that promote or facilitate illness progression, allowing doctors to provide patients with a potent new and extremely safemode of disease treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lou Hawthorne
Chief Financial Officer
Song Schreiber
Browse more venture capital transactions:
Prev: 10/31/2023: Guidde venture capital transaction
Next: 10/31/2023: iQ3Connect venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs